Jayson Wang1, Justin Stebbing, Mark Bower. 1. Department of Oncology, Imperial College School of Medicine, Chelsea and Westminster Hospital, London, United Kingdom.
Abstract
BACKGROUND: Cancer in individuals living with HIV and AIDS is a common source of morbidity and mortality, especially in the underdeveloped world. As antiretrovirals are distributed with greater equity across the globe, individuals with HIV and AIDS are living longer and developing malignancies, as opposed to other opportunistic infections. OBJECTIVE: This article reviews the gender differences in studies of AIDS-associated cancers, examining factors related to transmission, treatment, and outcome. METHODS: MEDLINE, PubMed, Ovid, conference proceedings, and abstract books were searched from 1983 onward for English-language publications and data on gender differences related to AIDS-associated cancers. Relevant trials were similarly reviewed. The search terms used were women or gender, cancer or tumor or malignancy, lymphoma or Kaposi, and HIV or AIDS. RESULTS: We found that studies in established market economies have focused predominantly on men, although a wider view suggests that the rapidly growing rates of HIV infection among women should prompt specific oncologic challenges. CONCLUSION: Immunosuppression-induced malignancies in women, Kaposi sarcoma in particular, are likely to represent a global issue in the future.
BACKGROUND:Cancer in individuals living with HIV and AIDS is a common source of morbidity and mortality, especially in the underdeveloped world. As antiretrovirals are distributed with greater equity across the globe, individuals with HIV and AIDS are living longer and developing malignancies, as opposed to other opportunistic infections. OBJECTIVE: This article reviews the gender differences in studies of AIDS-associated cancers, examining factors related to transmission, treatment, and outcome. METHODS: MEDLINE, PubMed, Ovid, conference proceedings, and abstract books were searched from 1983 onward for English-language publications and data on gender differences related to AIDS-associated cancers. Relevant trials were similarly reviewed. The search terms used were women or gender, cancer or tumor or malignancy, lymphoma or Kaposi, and HIV or AIDS. RESULTS: We found that studies in established market economies have focused predominantly on men, although a wider view suggests that the rapidly growing rates of HIV infection among women should prompt specific oncologic challenges. CONCLUSION: Immunosuppression-induced malignancies in women, Kaposi sarcoma in particular, are likely to represent a global issue in the future.
Authors: Pasquale Rescigno; Rossella Di Trolio; Carlo Buonerba; Gaia De Fata; Piera Federico; Davide Bosso; Antonella Virtuoso; Michela Izzo; Tania Policastro; Luca Vaccaro; Gianfranco Cimmino; Francesco Perri; Elide Matano; Mario Delfino; Sabino De Placido; Giovannella Palmieri; Giuseppe Di Lorenzo Journal: World J Clin Oncol Date: 2013-05-10
Authors: Daoshan Zheng; Cecilia Williams; Jeremy A Vold; Justin H Nguyen; Denise M Harnois; Sanjay P Bagaria; Sarah A McLaughlin; Zhaoyu Li Journal: Cancer Lett Date: 2018-09-14 Impact factor: 8.679
Authors: Warren Phipps; Fred Ssewankambo; Huong Nguyen; Misty Saracino; Anna Wald; Lawrence Corey; Jackson Orem; Andrew Kambugu; Corey Casper Journal: PLoS One Date: 2010-11-12 Impact factor: 3.240
Authors: Carla Andréa Avelar Pires; Marcos Antonio Neves Noronha; Julius Caesar Mendes Soares Monteiro; Albert Luiz Costa da Costa; José Maria de Castro Abreu Júnior Journal: An Bras Dermatol Date: 2018 Jul-Aug Impact factor: 1.896
Authors: Helena Lucia Barroso Dos Reis; Dennis de Carvalho Ferreira; Neide Aparecida Tosato Boldrini; Carolina Galvão; João Victor Jacomele Caldas; Marize Freitas Santos Neves; Philippe Godefroy Journal: BMC Infect Dis Date: 2019-12-30 Impact factor: 3.090